Company news
Hikma Pharmaceuticals Plc (LSE:HIK) news
Hikma Pharmaceuticals Plc news releases on 6ix. Latest, Nov 25, 2015: Hikma announces sale of Ben Venue manufacturing
Press releases — page 4
Hikma announces sale of Ben Venue manufacturing
November 25, 2015
Resolution to FDA Warning Letter
November 18, 2015
Block Listing of Share
October 22, 2015
Audit Tender
September 18, 2015
Hikma agrees to acquire EIMC United Pharmaceutical
September 8, 2015
Interim Results
August 19, 2015
Hikma Founder Samih Darwazah passes away
May 18, 2015
AGM Trading Update
May 14, 2015
Hikma launches caffeine citrate injection
May 12, 2015
Hikma prices debut $500 million five-year eurobond
April 1, 2015
Fixed income investor meetings
March 25, 2015
Hikma Delivers Insights at World Economic Forum
January 27, 2015
Notification of major interest in shares
January 21, 2015
Hikma to launch colchicine 0.6mg capsules
January 12, 2015
Interim Management Statement
November 6, 2014
Hikma announces receipt of Warning Letter from FDA
October 24, 2014
Statement re Colchicine
October 10, 2014
Regulatory Approval Colchicine
September 30, 2014
Dividend Declaration
August 20, 2014
Notice of Interim Results Announcement
August 7, 2014
Results of AGM
May 15, 2014
Successful resolution to US FDA warning letter
April 2, 2014
Notification of major interests in shares
February 27, 2014
Block Listing of Shares
February 21, 2014
Re Agreement
November 20, 2013
Hikma entering Ethiopian pharmaceutical market
September 18, 2013
Signing of Exclusive Agreement with Theravance
July 1, 2013
Hikma update on global Injectables business
April 17, 2013
Preliminary Results
March 13, 2013
Response to unsolicited enquiries
March 1, 2013
Hikma signs agreement with EffRx
February 4, 2013
Non Regulatory Announcement
January 3, 2013
Product Launch
December 13, 2012
Building Public Trust Awards - Highly Commended
November 27, 2012
Hikma & GP Pharm signs license & supply agreement
October 22, 2012
Injectables Analyst and Investor Day USA
October 11, 2012
Half Yearly Report
August 16, 2012
Annual Financial Report & AGM Notice
April 13, 2012
Tender Offer
January 17, 2012
Hikma in-licenses proprietary injectable product
August 17, 2011
Hikma enhances its API sourcing capabilities
July 11, 2011
Statement re Completion of Acquisition
May 3, 2011
Re Agreement with Unimark Remedies Limited
April 15, 2011
Appointments
January 24, 2011
Product Update
October 18, 2010
Block Listing for Share Schem
October 15, 2010
Company Update
October 1, 2010
Voting Rights and Capital
August 4, 2010
Voting Rights & Capital
May 5, 2010
Hikma expands in the Algerian
April 12, 2010